Factors associated with emergency department (ED) attendance during last month of life
the ONA take:
According to a new study published in the Journal of Clinical Oncology, researchers from King's College London Cicely Saunders Institute in London, United Kingdom, have identified demographic and environmental factors associated with an increased risk of emergency department visits by patients with cancer during the final month of life.
For the study, researchers sought to investigate factors associated with emergency department attendance by patients with cancer during the last month of their lives. They analyzed data from five electronic databases and identified 30 studies that investigated emergency department attendance at the end of the lives of patients with cancer.
The studies included nearly 1.2 million patients from five countries and reported 13 environmental, five clinical, and three demographic factors in total.
Results showed an increased risk of emergency department attendance was associated with black race (OR = 1.45; 95% CI: 1.40 - 1.50), male gender (OR = 1.24; 95% CI: 1.19 - 1.29), having lung cancer (OR = 1.17; 95% CI: 1.10 - 1.23), and those of low socioeconomic status (OR = 1.15; 95% CI: 1.10 - 1.19).
Patients receiving palliative care were less likely to have an emergency department visit during the last month of life (OR = 0.43; 95% CI: 0.36 - 0.51).
Demographic and environmental factors associated with an increased risk of emergency department visits by patients with cancer.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
- Colorectal Cancer Screening Rate Increased by Digital Self-Ordering
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|